Left group MEP accuses the EU of prioritising the profits of private companies, and pledges to continue opposing the pharmaceutical reform

Médecins Sans Frontières has launched a tool kit for costing clinical research and is urging others to use it to increase transparency

The first EU-funded research project into psychedelic drugs is a step on the way to legitimise the field and should lead to more funding

MEPs voted to adopt their negotiating position on the controversial reform, but it will not be finalised until after the European elections in June. Despite concessions, the pharma industry is not happy

After long negotiations MEPs agreed on the EU’s pharmaceutical reform. It includes longer exclusivity for data filed to get marketing approval for new drugs. But pharma still isn’t happy